Fundz

Abiogen Pharma Acquired Altamedics

PRIVATEDec 08, 2022

Acquiring Company

Abiogen Pharma

Acquired Company

Altamedics

ManufacturingBiotechnologyHealth CarePharmaceuticalManufacturingBiotechnology

Description

Abiogen Pharma S.p.A. completes the acquisition of the German pharmaceutical distribution company Altamedics GmbH which will become Abiogen's first foreign branch. Altamedics is based in Cologne and operates in several international markets. Its business is focusses on the distribution of pharmaceuticals in hospital settings, as well as of specialty and high-value-added products.

Quick answer

Abiogen Pharma is acquiring Altamedics, announced December 8, 2022.

How much did Abiogen Pharma pay for Altamedics?
The deal value was not disclosed.
What does Abiogen Pharma do?
Abiogen Pharma is headquartered in Pisa, Italy.

Source: Fundz verified event record.

Other recent acquisitions in Pharmaceutical and Manufacturing

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Abiogen Pharma, and when

When Abiogen Pharma changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Abiogen Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Abiogen Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Abiogen Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Abiogen Pharma

About

Abiogen Pharma is headquartered in Pisa, Italy. Since 1997, its business spans across several integrated areas: research and development, manufacturing of pharmaceuticals with its own brand or under third-party contracts, and marketing of own and licensed drugs. Its target therapeutic areas include bone metabolism, pain treatment, as well as respiratory, metabolic (diabetes) and dermatological disorders. With 195 million euros in revenue (2021) and 450 employees, it ranks among the 15 largest Italian pharmaceutical companies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Abiogen Pharma makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Abiogen Pharma's next move

Learn about Strategic plan

Frequently asked

Who acquired Altamedics?

Altamedics was acquired by Abiogen Pharma. The deal was reported on December 8, 2022. Abiogen Pharma is headquartered in Pisa, Italy. Abiogen Pharma is privately held and operates in Manufacturing.

When did Abiogen Pharma acquire Altamedics?

Abiogen Pharma's acquisition of Altamedics was reported on December 8, 2022. Abiogen Pharma S.p.A. completes the acquisition of the German pharmaceutical distribution company Altamedics GmbH which will become Abiogen's first foreign branch. Altamedics is based in Cologne and operates in several international markets. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Altamedics do?

Altamedics was established in 2009 in Cologne, Germany. It is privately held, operating in Manufacturing.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.